Cartesian Therapeutics (RNAC)
Develops outpatient mRNA CAR-T candidates for autoimmune diseases, led by Descartes-08.
$7.91
vs last close−0.17 (−2.10%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 28.84% | 8.73M shares | |
|---|---|---|---|
| 101 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 54.58% | 16.51M shares | |
| 16 holders · as of Apr 6, 2026 | |||
| Other | ≈ 16.58% | 5.02M shares | |
| remainder | |||
30.26M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
101 holders · 8.73M shares · 29 new positions · 72 increased · 12 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Squarepoint Ops LLC | 2.25M | 7.45% | +16.1K | Aug 14, 2026 |
| BlackRock, Inc. | 819.2K | 2.71% | +220.1K | Aug 7, 2026 |
| 683 Capital Management, LLC | 650.0K | 2.15% | +320.0K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 555.8K | 1.84% | +148.2K | Aug 13, 2026 |
| FMR LLC | 368.4K | 1.22% | −431.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 356.5K | 1.18% | +92.8K | Aug 12, 2026 |
| AQR Capital Management LLC | 356.5K | 1.18% | +272.4K | Aug 14, 2026 |
| Millennium Management LLC | 309.9K | 1.02% | +25.6K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Timothy A. Springerincl. TAS Partners LLC, Chafen Lu | 36.90% | 9.56M | 13D | Jan 15, 2025 |
| Murat Kalayogluincl. Elizabeth Hoge, Sinan Kalayoglu +1 more | 19.90% | 5.83M | 13D | Apr 2, 2026 |
| Squarepoint Ops LLC | 8.30% | 2.21M | 13G | Mar 13, 2026 |
| JPMorgan Chase & Co. | 6.10% | 1.68M | 13G | Apr 25, 2025 |
| Barclays PLC | 5.99% | 1.76M | 13G | Aug 13, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 6, 2026 | Blaine Davisofficer: Chief Financial Officer | Sale | 10,591 | $6.82 | 121,220 |
| Jan 6, 2026 | Milos Miljkovicofficer: Chief Medical Officer | Sale | 3,573 | $6.82 | 58,820 |
| Jan 6, 2026 | Carsten Brunndirector, officer: President and CEO | Sale | 23,766 | $6.82 | 323,530 |
| Dec 4, 2025 | Timothy C. Barabedirector | Purchase | 30,000 | $6.86 | 54,366 |
House and Senate disclosures
Not reported.